Quarterly report pursuant to Section 13 or 15(d)

SELECTED FINANCIAL STATEMENT CAPTIONS - LIABILITIES (Details)

v3.22.2.2
SELECTED FINANCIAL STATEMENT CAPTIONS - LIABILITIES (Details) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Accounts payable:    
Clinical and regulatory expenses $ 444 $ 534
Professional fees 579 477
Selling expenses 1,138 932
Manufacturing costs 532 378
Non-employee board member compensation 401 136
Other vendors 313 262
Total accounts payable 3,407 2,719
Accrued interest payable, related parties 325 91
Accrued interest payable 1,673 579
Accrued expenses:    
Payroll expenses 1,196 1,097
Government rebates and other rebates 4,157 4,371
Other accrued expenses 376 332
Total accrued expenses 5,729 5,800
Total accounts payable and accrued expenses $ 11,134 $ 9,189